Related Experiment Video
Updated: Apr 26, 2026

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
Published on: February 18, 2022
Integrative analysis of ocular complications in atherosclerosis unveils pathway convergence and crosstalk
Akanksha Gupta1, Pallavi Mohanty, Sonika Bhatnagar
1Division of Biotechnology, Netaji Subhas Institute of Technology , New Delhi , India.
Abstract:
Atherosclerosis is a life-threatening disease and a major cause of mortalities worldwide. While many of the atherosclerotic sequelae are reflected as microvascular effects in the eye, the molecular mechanisms of their development is not yet known. In this study, we employed a systems biology approach to unveil the most significant events and key molecular mediators of ophthalmic sequelae caused by atherosclerosis. Literature mining was used to identify the proteins involved in both atherosclerosis and ophthalmic diseases. A protein-protein interaction (PPI) network was prepared using the literature-mined seed nodes. Network topological analysis was carried out using Cytoscape, while network nodes were annotated using database for annotation, visualization and integrated discovery in order to identify the most enriched pathways and processes. Network analysis revealed that mitogen-activated protein kinase 1 (MAPK1) and protein kinase C occur with highest betweenness centrality, degree and closeness centrality, thus reflecting their functional importance to the network. Our analysis shows that atherosclerosis-associated ophthalmic complications are caused by the convergence of neurotrophin signaling pathways, multiple immune response pathways and focal adhesion pathway on the MAPK signaling pathway. The PPI network shares features with vasoregression, a process underlying multiple vascular eye diseases. Our study presents a first clear and composite picture of the components and crosstalk of the main pathways of atherosclerosis-induced ocular diseases. The hub bottleneck nodes highlight the presence of molecules important for mediating the ophthalmic complications of atherosclerosis and contain five established drug targets for future therapeutic modulation efforts.
Insights
Atherosclerosis can cause eye problems. This study used systems biology to find key molecular players, revealing MAPK signaling as central to these complications.
Area of Science:
- Cardiovascular Biology
- Ophthalmology
- Systems Biology
- Molecular Medicine
Background:
- Atherosclerosis is a leading global cause of mortality.
- Ophthalmic complications of atherosclerosis are common but poorly understood at the molecular level.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying ophthalmic complications of atherosclerosis.
- To identify key molecular mediators and pathways involved in these ocular diseases.
Main Methods:
- Literature mining to identify proteins in atherosclerosis and ophthalmic diseases.
- Construction and analysis of a protein-protein interaction (PPI) network using Cytoscape.
- Network topological and pathway enrichment analysis.
Main Results:
- Network analysis identified mitogen-activated protein kinase 1 (MAPK1) and protein kinase C as critical nodes.
- Atherosclerosis-associated ophthalmic complications result from the convergence of neurotrophin, immune response, and focal adhesion pathways onto the MAPK signaling pathway.
- The PPI network exhibits features of vasoregression, common in vascular eye diseases.
Conclusions:
- This study provides a comprehensive view of pathways involved in atherosclerosis-induced ocular diseases.
- Key molecular mediators and pathway crosstalks were identified.
- Hub nodes highlight potential therapeutic targets for ophthalmic complications of atherosclerosis.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
07:44In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography
Published on: July 24, 2020
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Accessory Structures of the Eye
Atherosclerosis III: Management